Health & Medicine
Measles has no treatments. Getting some may not be easy
Vaccination remains the priority, but some researchers are looking for drugs to fight the virus in people who don't get the shot.
Every print subscription comes with full digital access
Vaccination remains the priority, but some researchers are looking for drugs to fight the virus in people who don't get the shot.
We summarize the week's scientific breakthroughs every Thursday.
Over time, immune cells acquire mutations that promote atherosclerosis. Lifestyle changes may offset these DNA glitches, new mouse data suggest.
In a first, researchers genetically modified hookworms. It’s a step toward turning the parasites into living pharmacies.
In a clinical trial, an experimental antibody reduced lean-mass loss in people on a GLP-1 drug. Whether that improves health is unclear.
Making social connection part of job design, whether people work remotely, hybrid or in-person, is key to supporting employees‘ well-being.
Answers to key questions could help public health officials develop Ebola treatments, predict the outbreak’s trajectory and prevent a future one.
The cold-loving yeasts from Ötzi’s remains suggest the Iceman’s microbiome may not be completely frozen in time.
A new survey estimates 8 million young people use AI chatbots for help when stressed, angry or sad, an increase from 2024.
Tones, oddball sounds and words can spark brain cell responses, hinting at nuanced processing without consciousness.
Daraxonrasib, which nearly doubled patients' survival time, fights the disease in a new way. It bear-hugs a cancer protein that drives cell growth.
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.
Not a subscriber?
Become one now.